Co-Authors
This is a "connection" page, showing publications co-authored by Sherief Abd-Elsalam and Shaimaa Soliman.
Connection Strength
1.833
-
Response to "Randomized Controlled Trials on COVID-19 Should be Accurate and Trustworthy". Am J Trop Med Hyg. 2021 08 30; 106(1):370.
Score: 0.965
-
Clinical study evaluating the efficacy of ivermectin in COVID-19 treatment: A randomized controlled study. J Med Virol. 2021 Oct; 93(10):5833-5838.
Score: 0.237
-
Do Zinc Supplements Enhance the Clinical Efficacy of Hydroxychloroquine?: a Randomized, Multicenter Trial. Biol Trace Elem Res. 2021 Oct; 199(10):3642-3646.
Score: 0.229
-
Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study. Am J Trop Med Hyg. 2020 10; 103(4):1635-1639.
Score: 0.226
-
Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials. Nat Commun. 2021 May 14; 12(1):3001.
Score: 0.059
-
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials. Nat Commun. 2021 04 15; 12(1):2349.
Score: 0.059
-
Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study. Arch Virol. 2021 Mar; 166(3):949-954.
Score: 0.058